Michael R Schmidt1, Nicolaj B Støttrup2, Hussain Contractor3, Janus A Hyldebrandt4, Mogens Johannsen5, Christian M Pedersen2, Rune Birkler5, Houman Ashrafian3, Keld E Sørensen2, Rajesh K Kharbanda3, Andrew N Redington6, Hans E Bøtker2. 1. Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej, Aarhus N, DK-8200, Denmark. Electronic address: Michael.rahbek@ki.au.dk. 2. Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej, Aarhus N, DK-8200, Denmark. 3. Department of Cardiology, The John Radcliffe, Headley Way, Headington, Oxford, OX3 9DU, United Kingdom. 4. Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Skejby, Brendstrupgaardsvej, Aarhus N, DK-8200, Denmark. 5. Department of Forensic Medicine, Aarhus University Hospital, Skejby, Brendstrupgaardsvej, Aarhus N, DK-8200, Denmark. 6. Division of Cardiology, Hospital for Sick Children, Toronto, M5G 1X8, Canada.
Abstract
BACKGROUND: While remote ischemic preconditioning (rIPC) protects the mature heart against ischemia-reperfusion (IR) injury, the effect on the neonatal heart is not known. The neonatal heart relies almost solely on carbohydrate metabolism, which is modified by rIPC in the mature heart. We hypothesized that rIPC combined with metabolic support with glucose-insulin (GI) infusion improves cardiac function and reduces infarct size after IR injury in neonatal piglets in-vivo. METHODS AND RESULTS: 32 newborn piglets were randomized into 4 groups: control, GI, GI+rIPC and rIPC. GI and GI+rIPC groups received GI infusion continuously from 40 min prior to ischemia. rIPC and GI+rIPC groups underwent four cycles of 5 min limb ischemia. Myocardial IR injury was induced by 40 min occlusion of the left anterior descending artery followed by 2 h reperfusion. Myocardial lactate concentrations were assessed in microdialysis samples analyzed by mass spectrometry. Infarct size was measured using triphenyltetrazolium chloride staining. Systolic recovery (dP/dt(max) as % of baseline) after 2 h reperfusion was 68.5±13.8% in control, 53.7±11.2% in rIPC (p<0.05), and improved in GI (83.6±18.8%, p<0.05) and GI+rIPC (87.0±15.7%, p<0.01). CONCLUSION: rIPC+GI protects the neonatal porcine heart against IR injury in-vivo. rIPC alone has detrimental metabolic and functional effects that are abrogated by simultaneous GI infusion.
BACKGROUND: While remote ischemic preconditioning (rIPC) protects the mature heart against ischemia-reperfusion (IR) injury, the effect on the neonatal heart is not known. The neonatal heart relies almost solely on carbohydrate metabolism, which is modified by rIPC in the mature heart. We hypothesized that rIPC combined with metabolic support with glucose-insulin (GI) infusion improves cardiac function and reduces infarct size after IR injury in neonatal piglets in-vivo. METHODS AND RESULTS: 32 newborn piglets were randomized into 4 groups: control, GI, GI+rIPC and rIPC. GI and GI+rIPC groups received GI infusion continuously from 40 min prior to ischemia. rIPC and GI+rIPC groups underwent four cycles of 5 min limb ischemia. Myocardial IR injury was induced by 40 min occlusion of the left anterior descending artery followed by 2 h reperfusion. Myocardial lactate concentrations were assessed in microdialysis samples analyzed by mass spectrometry. Infarct size was measured using triphenyltetrazolium chloride staining. Systolic recovery (dP/dt(max) as % of baseline) after 2 h reperfusion was 68.5±13.8% in control, 53.7±11.2% in rIPC (p<0.05), and improved in GI (83.6±18.8%, p<0.05) and GI+rIPC (87.0±15.7%, p<0.01). CONCLUSION:rIPC+GI protects the neonatal porcine heart against IR injury in-vivo. rIPC alone has detrimental metabolic and functional effects that are abrogated by simultaneous GI infusion.
Authors: Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch Journal: Basic Res Cardiol Date: 2018-08-17 Impact factor: 17.165
Authors: André Heinen; Friederike Behmenburg; Aykut Aytulun; Maximilian Dierkes; Lea Zerbin; Wolfgang Kaisers; Maximilian Schaefer; Tanja Meyer-Treschan; Susanne Feit; Inge Bauer; Markus W Hollmann; Ragnar Huhn Journal: J Transl Med Date: 2018-04-27 Impact factor: 5.531
Authors: Tamás Baranyai; Csilla Terézia Nagy; Gábor Koncsos; Zsófia Onódi; Melinda Károlyi-Szabó; András Makkos; Zoltán V Varga; Péter Ferdinandy; Zoltán Giricz Journal: Cardiovasc Diabetol Date: 2015-11-18 Impact factor: 9.951